After announcing the state would initiate coverage of GLP-1s to combat obesity in September 2022 as part of their state employee health plan, the state reversed course and in January 2025 announced it was opting to end that coverage beginning July 1, 2025
doi: 10.1038/s41418-025-01587-4 57 WuKFeiLWangXLeiYYuLXuWet al
While IV therapy is highly effective because it delivers the antioxidant directly into the bloodstream, bypassing the digestive tract entirely, it is also expensive, invasive, and impractical for daily, long-term management
Potential Interactions with Other Treatments Ghk-Cu is generally safe to use alongside most treatments, but its important to avoid combining it with antioxidants like vitamin C, which can interfere with its copper-binding properties
Ipamorelin: Mechanism & Research Ipamorelin is a pentapeptide ghrelin receptor agonist that stimulates growth hormone secretion through a distinct pathway from CJC-1295
Want it in your cells